SonicPrecision develops technology to advance catheter ablation for cardiac arrhythmias. The company focuses on setting new standards for lesion quality and durability assessment during treatment. This approach aims to ensure disease-free outcomes for patients undergoing cardiac ablation procedures.
Funding
Funding not disclosed
Founders
Product
Problem
Electrophysiologists face challenges in delivering precise and effective catheter ablation treatments for cardiac arrhythmias due to the inability to visualize heart tissue and assess therapy impact in real-time. This lack of direct feedback can lead to both over- and under-treatment, resulting in complications, reduced heart function, and arrhythmia recurrence. More than 20% of patients require repeat procedures within a year to achieve symptom relief.
Solution
SonicPrecision is developing a dual-energy (RF and PFA) ablation catheter with integrated ultrasound sensors to provide real-time visualization of cardiac tissue during ablation procedures. The embedded ultrasound technology enables electrophysiologists to monitor catheter contact, stability, and tissue properties, such as myocardial wall thickness, enhancing procedure safety and ablation quality. This approach facilitates a tailored treatment strategy, ensuring precise therapy delivery and improved clinical outcomes by minimizing complications and the need for repeat procedures. The catheter aims to provide direct treatment feedback, allowing for personalized catheter ablation treatment.
Target Audience
The primary target audience includes electrophysiologists and medical professionals specializing in cardiac arrhythmia treatments.
Features
- Dual energy source (RF and PFA) ablation catheter
- Embedded ultrasound sensors in the tip for real-time tissue visualization
- Real-time monitoring of catheter contact and stability
- Assessment of myocardial wall thickness during procedures
- Enhanced procedure safety and ablation quality
- Tailored approach for precise treatment delivery